Works matching IS 0195668X AND DT 2024 AND VI 45 AND IP 4

Results: 19

Focus on vascular biology: new therapeutic targets in atherosclerosis, aortic dissection, and peripheral artery disease.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 239, doi. 10.1093/eurheartj/ehae004

By:

Crea, Filippo

Publication type:

Article

Correction to: Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry.

Published in:: 2024
Publication type:: Correction Notice

Correction to: Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.

Published in:: 2024
Publication type:: Correction Notice

Drugging the foam cell: identifying P2Y6 antagonists that limit atherosclerosis.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 284, doi. 10.1093/eurheartj/ehad846

By:

Rayner, Katey J

Publication type:

Article

Correction to: HFrEF phenotyping in real life.

Published in:: European Heart Journal, 2024, v. 45, n. 4, p. 283, doi. 10.1093/eurheartj/ehad839
Publication type:: Article

A conundrum of arterialized capillaries and vascular dilation in chronic limb-threatening ischaemia.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 265, doi. 10.1093/eurheartj/ehad826

By:

Ganta, Vijay C;
Jones, W Schuyler;
Annex, Brian H

Publication type:

Article

Macrophage P2Y6 receptor deletion attenuates atherosclerosis by limiting foam cell formation through phospholipase Cβ/store-operated calcium entry/calreticulin/scavenger receptor A pathways.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 268, doi. 10.1093/eurheartj/ehad796

By:

Li, Yehong;
Zhou, Mengze;
Li, Huanqiu;
Dai, Chen;
Yin, Li;
Liu, Chunxiao;
Li, Yuxin;
Zhang, Enming;
Dong, Xinli;
Ji, Hui;
Hu, Qinghua

Publication type:

Article

Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 309, doi. 10.1093/eurheartj/ehad789

By:

Schneider, Simon R;
Müller, Julian;
Bauer, Meret;
Mayer, Laura;
Lüönd, Lea;
Ulrich, Tanja;
Furian, Michael;
Forrer, Aglaia;
Carta, Arcangelo;
Schwarz, Esther I;
Bloch, Konrad E;
Lichtblau, Mona;
Ulrich, Silvia

Publication type:

Article

Routine use of extracorporeal life support in cardiogenic shock after acute myocardial infarction: the jury is still out.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 253, doi. 10.1093/eurheartj/ehad760

By:

Pedicino, Daniela;
Vergallo, Rocco

Publication type:

Article

Inflammation contributes to the pathogenic effects of subclinical atherosclerosis.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 313, doi. 10.1093/eurheartj/ehad701

By:

Sánchez-Cabo, Fátima;
Fuster, Valentín;
Lara-Pezzi, Enrique

Publication type:

Article

Unspoken science: exploring the significance of body language in science and academia.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 250, doi. 10.1093/eurheartj/ehad598

By:

Patil, Mansi;
Patil, Vishal;
Katre, Unisha

Publication type:

Article

Critical limb-threatening ischaemia and microvascular transformation: clinical implications.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 255, doi. 10.1093/eurheartj/ehad562

By:

Tarvainen, Santeri;
Wirth, Galina;
Juusola, Greta;
Hautero, Olli;
Kalliokoski, Kari;
Sjöros, Tanja;
Nikulainen, Veikko;
Taavitsainen, Jouni;
Hytönen, Jarkko;
Frimodig, Crister;
Happonen, Krista;
Selander, Tuomas;
Laitinen, Tomi;
Hakovirta, Harri H;
Knuuti, Juhani;
Laham-Karam, Nihay;
Hartikainen, Juha;
Mäkinen, Kimmo;
Ylä-Herttuala, Seppo;
Korpisalo, Petra

Publication type:

Article

On target inhibition of vascular smooth muscle cell phenotypic transition underpins TNF–OXPHOS–AP-1 as a promising avenue for anti-remodelling interventions in aortic dissection and rupture.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 306, doi. 10.1093/eurheartj/ehad679

By:

Miteva, Kapka

Publication type:

Article

Exacerbating the burden of cardiovascular disease: how can we address cardiopulmonary risk in individuals with chronic obstructive pulmonary disease?

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 247, doi. 10.1093/eurheartj/ehad669

By:

Shrikrishna, Dinesh;
Taylor, Clare J;
Stonham, Carol;
Gale, Chris P

Publication type:

Article

Percutaneous closure of infantile postoperative left ventricular pseudoaneurysm exclusively under transthoracic echocardiography guidance.

Published in:

2024

By:

Mi, Huai-Xue;
Wu, Peng-Peng;
Hongxin, Li

Publication type:

Case Study

Immunology and atherosclerosis: is there an individual ID which defines our susceptibility?

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 312, doi. 10.1093/eurheartj/ehad700

By:

Lozano, Iñigo;
Suárez, Ana;
Rodriguez-Carrio, Javier

Publication type:

Article

Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy.

Published in:

2024

By:

Nakajima, Akihiro;
Okutsu, Masaaki;
Nakamura, Sunao

Publication type:

Case Study

The activator protein-1 complex governs a vascular degenerative transcriptional programme in smooth muscle cells to trigger aortic dissection and rupture.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 287, doi. 10.1093/eurheartj/ehad534

By:

Luo, Yongting;
Luo, Junjie;
An, Peng;
Zhao, Yuanfei;
Zhao, Wenting;
Fang, Zhou;
Xia, Yi;
Zhu, Lin;
Xu, Teng;
Zhang, Xu;
Zhou, Shuaishuai;
Yang, Mingyan;
Li, Jiayao;
Zhu, Junming;
Liu, Yongmin;
Li, Haiyang;
Gong, Ming;
Liu, Yuyong;
Han, Jie;
Guo, Huiyuan

Publication type:

Article

Creation of next generation of diverse cardiovascular physician–scientists from developing countries: insights from Research Council of Pakistan.

Published in:

European Heart Journal, 2024, v. 45, n. 4, p. 243, doi. 10.1093/eurheartj/ehad493

By:

Khan, Muhammad Shahzeb;
Fatima, Kaneez;
Butler, Javed

Publication type:

Article

Works matching IS 0195668X AND DT 2024 AND VI 45 AND IP 4

Focus on vascular biology: new therapeutic targets in atherosclerosis, aortic dissection, and peripheral artery disease.

Correction to: Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry.

Correction to: Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.

Drugging the foam cell: identifying P2Y<sub>6</sub> antagonists that limit atherosclerosis.

Correction to: HFrEF phenotyping in real life.

A conundrum of arterialized capillaries and vascular dilation in chronic limb-threatening ischaemia.

Macrophage P2Y<sub>6</sub> receptor deletion attenuates atherosclerosis by limiting foam cell formation through phospholipase C<sub>β</sub>/store-operated calcium entry/calreticulin/scavenger receptor A pathways.

Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy.

Routine use of extracorporeal life support in cardiogenic shock after acute myocardial infarction: the jury is still out.

Inflammation contributes to the pathogenic effects of subclinical atherosclerosis.

Unspoken science: exploring the significance of body language in science and academia.

Critical limb-threatening ischaemia and microvascular transformation: clinical implications.

On target inhibition of vascular smooth muscle cell phenotypic transition underpins TNF–OXPHOS–AP-1 as a promising avenue for anti-remodelling interventions in aortic dissection and rupture.

Exacerbating the burden of cardiovascular disease: how can we address cardiopulmonary risk in individuals with chronic obstructive pulmonary disease?

Percutaneous closure of infantile postoperative left ventricular pseudoaneurysm exclusively under transthoracic echocardiography guidance.

Immunology and atherosclerosis: is there an individual ID which defines our susceptibility?

Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy.

The activator protein-1 complex governs a vascular degenerative transcriptional programme in smooth muscle cells to trigger aortic dissection and rupture.

Creation of next generation of diverse cardiovascular physician–scientists from developing countries: insights from Research Council of Pakistan.